Healthcare Sector Stocks
The Healthcare sector has a total of 1049 stocks, with a combined market cap of $9.14 trillion, total revenue of $4.67 trillion and a weighted average PE ratio of 48.56.
Market Cap
9.14T
Revenue
4.67T
Profits
188.32B
PE Ratio
48.56
Profit Margin
4.04%
Dividend Yield
0.39%
1048 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | LLY | Eli Lilly and Company | 1.00T | 0.03% | 2,035,395 | 79.67B |
| 2 | JNJ | Johnson & Johnson | 643.64B | -0.76% | 6,114,414 | 97.93B |
| 3 | ABBV | AbbVie Inc. | 443.39B | 0.86% | 3,864,751 | 64.39B |
| 4 | MRK | Merck & Co., Inc. | 363.98B | -0.63% | 8,335,072 | 66.57B |
| 5 | UNH | UnitedHealth Group Incorporated | 352.81B | -1.94% | 7,696,299 | 450.53B |
| 6 | NVS | Novartis AG | 261.94B | -0.16% | 2,876,486 | 56.69B |
| 7 | AZN | AstraZeneca PLC | 244.76B | -1.94% | 3,830,414 | 61.37B |
| 8 | TMO | Thermo Fisher Scientific Inc. | 223.95B | 0.44% | 1,961,184 | 46.34B |
| 9 | AMGN | Amgen Inc. | 211.53B | -0.48% | 2,913,043 | 38.10B |
| 10 | NVO | Novo Nordisk A/S | 198.72B | -1.33% | 8,618,415 | 50.34B |
| 11 | ABT | Abbott Laboratories | 182.09B | -0.27% | 6,467,989 | 46.59B |
| 12 | GILD | Gilead Sciences, Inc. | 180.60B | -0.68% | 4,581,696 | 30.46B |
| 13 | PFE | Pfizer Inc. | 158.34B | -0.04% | 29,034,765 | 63.70B |
| 14 | DHR | Danaher Corporation | 144.01B | -0.19% | 2,764,758 | 25.11B |
| 15 | VRTX | Vertex Pharmaceuticals Incorporated | 132.08B | -1.47% | 957,773 | 12.59B |
| 16 | BMY | Bristol-Myers Squibb Company | 131.57B | -0.43% | 6,565,681 | 49.19B |
| 17 | ISRG | Intuitive Surgical, Inc. | 124.79B | 0.88% | 2,413,874 | 11.03B |
| 18 | CVS | CVS Health Corporation | 121.99B | -0.72% | 6,088,083 | 412.65B |
| 19 | MDT | Medtronic plc | 117.54B | -0.54% | 7,733,020 | 37.54B |
| 20 | SYK | Stryker Corporation | 105.63B | -0.38% | 5,493,919 | 25.84B |
| 21 | MCK | McKesson Corporation | 103.96B | 0.29% | 967,659 | 410.98B |
| 22 | SNY | Sanofi | 103.36B | -0.71% | 1,919,531 | 55.89B |
| 23 | GSK | GSK plc | 97.89B | 0.19% | 2,383,636 | 44.05B |
| 24 | HCA | HCA Healthcare, Inc. | 91.33B | 4.93% | 2,147,859 | 78.01B |
| 25 | ELV | Elevance Health, Inc. | 86.08B | -1.25% | 1,202,578 | 201.11B |
| 26 | REGN | Regeneron Pharmaceuticals, Inc. | 80.65B | -0.33% | 621,344 | 15.53B |
| 27 | CI | The Cigna Group | 73.50B | 0.85% | 1,550,711 | 282.38B |
| 28 | BSX | Boston Scientific Corporation | 65.16B | -0.04% | 17,949,153 | 21.00B |
| 29 | ARGX | argenx SE | 62.88B | -0.47% | 209,708 | 5.32B |
| 30 | COR | Cencora, Inc. | 61.70B | -0.42% | 1,214,964 | 332.77B |
| 31 | TAK | Takeda Pharmaceutical Company Limited | 58.38B | -0.60% | 1,563,251 | 28.42B |
| 32 | CAH | Cardinal Health, Inc. | 55.82B | -0.20% | 1,028,515 | 254.25B |
| 33 | MRNA | Moderna, Inc. | 54.14B | -3.36% | 8,525,235 | 2.23B |
| 34 | EW | Edwards Lifesciences Corporation | 49.67B | -0.62% | 2,736,761 | 6.51B |
| 35 | BDX | Becton, Dickinson and Company | 48.98B | 0.98% | 1,528,963 | 22.48B |
| 36 | HUM | Humana Inc. | 48.03B | -0.76% | 942,231 | 145.68B |
| 37 | NTRA | Natera, Inc. | 47.61B | 1.90% | 703,438 | 2.71B |
| 38 | MDLN | Medline Inc. | 44.77B | -1.84% | 5,226,708 | 29.94B |
| 39 | RVMD | Revolution Medicines, Inc. | 44.51B | 0.17% | 1,225,976 | - |
| 40 | TEVA | Teva Pharmaceutical Industries Limited | 42.94B | 0.24% | 3,986,519 | 17.32B |
| 41 | IQV | IQVIA Holdings Inc. | 42.30B | -0.86% | 1,088,655 | 16.98B |
| 42 | VEEV | Veeva Systems Inc. | 42.23B | -1.53% | 1,074,940 | 3.46B |
| 43 | A | Agilent Technologies, Inc. | 40.81B | -1.43% | 1,853,818 | 7.37B |
| 44 | IDXX | IDEXX Laboratories, Inc. | 40.58B | -0.97% | 556,386 | 4.55B |
| 45 | HLN | Haleon plc | 39.95B | -0.22% | 18,941,456 | 14.80B |
| 46 | ONC | BeOne Medicines AG | 39.91B | -0.14% | 619,577 | 6.13B |
| 47 | WAT | Waters Corporation | 39.77B | 0.47% | 741,638 | 4.64B |
| 48 | RPRX | Royalty Pharma plc | 34.84B | - | 4,338,972 | 2.54B |
| 49 | ALNY | Alnylam Pharmaceuticals, Inc. | 34.52B | -0.81% | 1,426,002 | 4.80B |
| 50 | ALC | Alcon Inc. | 33.35B | -1.00% | 1,963,801 | 10.86B |
| 51 | DXCM | DexCom, Inc. | 31.65B | -0.77% | 3,953,131 | 4.97B |
| 52 | CNC | Centene Corporation | 31.65B | -0.81% | 4,477,475 | 180.30B |
| 53 | RMD | ResMed Inc. | 31.47B | -0.50% | 1,199,479 | 5.65B |
| 54 | BIIB | Biogen Inc. | 31.14B | -0.83% | 694,332 | 10.03B |
| 55 | ILMN | Illumina, Inc. | 30.96B | -2.87% | 1,707,017 | 4.49B |
| 56 | ZTS | Zoetis Inc. | 30.29B | -0.34% | 5,440,555 | 9.53B |
| 57 | ROIV | Roivant Sciences Ltd. | 30.20B | 0.80% | 11,137,888 | 7.53M |
| 58 | GEHC | GE HealthCare Technologies Inc. | 29.44B | -2.40% | 3,572,970 | 21.27B |
| 59 | INSM | Insmed Incorporated | 28.13B | 3.13% | 2,841,946 | 1.14B |
| 60 | LH | Labcorp Holdings Inc. | 26.04B | -1.16% | 959,564 | 14.35B |
| 61 | DGX | Quest Diagnostics Incorporated | 25.99B | -0.02% | 789,245 | 11.56B |
| 62 | MTD | Mettler-Toledo International Inc. | 25.85B | -2.65% | 193,568 | 4.13B |
| 63 | INCY | Incyte Corporation | 25.54B | 1.29% | 1,271,389 | 5.82B |
| 64 | BNTX | BioNTech SE | 24.65B | -0.54% | 702,877 | 3.03B |
| 65 | PHG | Koninklijke Philips N.V. | 24.60B | -1.07% | 873,383 | 20.18B |
| 66 | WST | West Pharmaceutical Services, Inc. | 23.71B | -0.24% | 471,270 | 3.33B |
| 67 | GH | Guardant Health, Inc. | 21.84B | 1.12% | 1,115,552 | 1.18B |
| 68 | UTHR | United Therapeutics Corporation | 21.74B | 1.78% | 499,753 | 3.15B |
| 69 | THC | Tenet Healthcare Corporation | 21.67B | 3.87% | 721,853 | 21.81B |
| 70 | STE | STERIS plc | 20.97B | -1.53% | 499,068 | 6.04B |
| 71 | GMAB | Genmab A/S | 19.81B | -1.46% | 2,122,278 | 4.13B |
| 72 | VTRS | Viatris Inc. | 18.95B | -0.66% | 6,508,650 | 14.74B |
| 73 | ZBH | Zimmer Biomet Holdings, Inc. | 18.05B | 0.41% | 2,063,468 | 8.51B |
| 74 | ASND | Ascendis Pharma A/S | 17.13B | -3.44% | 496,769 | 1.20B |
| 75 | MEDP | Medpace Holdings, Inc. | 16.36B | -0.78% | 205,219 | 2.78B |
| 76 | NBIX | Neurocrine Biosciences, Inc. | 15.77B | 0.01% | 1,050,620 | 3.37B |
| 77 | JAZZ | Jazz Pharmaceuticals plc | 15.66B | 0.52% | 422,413 | 4.60B |
| 78 | SOLV | Solventum Corporation | 15.33B | -0.09% | 802,739 | 8.31B |
| 79 | BBIO | BridgeBio Pharma, Inc. | 14.87B | 1.77% | 2,288,672 | 713.07M |
| 80 | EXEL | Exelixis, Inc. | 14.45B | 1.14% | 1,730,968 | 2.44B |
| 81 | SMMT | Summit Therapeutics Inc. | 13.99B | 1.50% | 4,703,451 | - |
| 82 | RVTY | Revvity, Inc. | 13.82B | -2.54% | 1,881,758 | 2.91B |
| 83 | CRL | Charles River Laboratories International, Inc. | 13.29B | -0.86% | 789,179 | 4.00B |
| 84 | BTSG | BrightSpring Health Services, Inc. | 12.91B | -0.91% | 1,294,901 | 14.37B |
| 85 | MDGL | Madrigal Pharmaceuticals, Inc. | 12.63B | 2.34% | 280,554 | 1.28B |
| 86 | BAX | Baxter International Inc. | 12.61B | -1.89% | 5,298,326 | 11.47B |
| 87 | PEN | Penumbra, Inc. | 12.59B | 0.10% | 211,983 | 1.50B |
| 88 | CORT | Corcept Therapeutics Incorporated | 12.51B | 1.51% | 571,143 | 830.81M |
| 89 | BMRN | BioMarin Pharmaceutical Inc. | 12.47B | -0.34% | 1,949,550 | 3.41B |
| 90 | COO | The Cooper Companies, Inc. | 12.38B | -6.22% | 9,564,833 | 4.24B |
| 91 | ICLR | ICON Public Limited Company | 12.31B | 0.74% | 799,406 | 8.29B |
| 92 | HALO | Halozyme Therapeutics, Inc. | 12.19B | -0.85% | 1,744,013 | 1.66B |
| 93 | EHC | Encompass Health Corporation | 11.99B | 0.87% | 620,533 | 6.21B |
| 94 | FMS | Fresenius Medical Care AG | 11.87B | -0.53% | 366,454 | 22.19B |
| 95 | ELAN | Elanco Animal Health Incorporated | 11.77B | -1.75% | 3,875,391 | 5.02B |
| 96 | SNN | Smith & Nephew plc | 11.68B | -0.25% | 1,865,549 | 6.30B |
| 97 | ARWR | Arrowhead Pharmaceuticals, Inc. | 11.67B | -2.91% | 3,666,837 | 669.50M |
| 98 | DVA | DaVita Inc. | 11.67B | 1.64% | 687,871 | 14.01B |
| 99 | TECH | Bio-Techne Corporation | 11.33B | -0.08% | 1,986,612 | 1.22B |
| 100 | TEM | Tempus AI, Inc. | 11.06B | -4.68% | 6,579,725 | 1.43B |
| 101 | AXSM | Axsome Therapeutics, Inc. | 11.03B | 1.35% | 421,846 | 776.57M |
| 102 | ALGN | Align Technology, Inc. | 10.86B | -0.37% | 1,107,133 | 4.14B |
| 103 | GKOS | Glaukos Corporation | 10.60B | -2.84% | 587,074 | 612.84M |
| 104 | UHS | Universal Health Services, Inc. | 10.36B | 2.26% | 891,569 | 18.11B |
| 105 | KRYS | Krystal Biotech, Inc. | 10.30B | -0.90% | 222,170 | 440.48M |
| 106 | CYTK | Cytokinetics, Incorporated | 10.30B | -1.65% | 1,413,013 | 67.67M |
| 107 | ABVX | ABIVAX Société Anonyme | 10.25B | 0.43% | 974,814 | 5.67M |
| 108 | MOH | Molina Healthcare, Inc. | 10.11B | -1.11% | 736,568 | 42.47B |
| 109 | BIO | Bio-Rad Laboratories, Inc. | 10.08B | -0.83% | 176,998 | 2.59B |
| 110 | AVTR | Avantor, Inc. | 10.06B | -2.43% | 7,845,000 | 6.56B |
| 111 | RDY | Dr. Reddy's Laboratories Limited | 10.01B | - | 3,499,873 | 3.50B |
| 112 | GMED | Globus Medical, Inc. | 10.01B | -0.69% | 1,518,183 | 3.14B |
| 113 | ENSG | The Ensign Group, Inc. | 9.93B | 0.72% | 660,104 | 5.49B |
| 114 | HSIC | Henry Schein, Inc. | 9.80B | -1.00% | 754,089 | 13.60B |
| 115 | OSCR | Oscar Health, Inc. | 9.79B | -3.79% | 5,195,526 | 15.32B |
| 116 | PRAX | Praxis Precision Medicines, Inc. | 9.64B | -2.04% | 382,948 | 7.46M |
| 117 | KYMR | Kymera Therapeutics, Inc. | 9.60B | -0.89% | 762,780 | 105.00M |
| 118 | PODD | Insulet Corporation | 9.57B | -3.06% | 2,058,040 | 3.05B |
| 119 | PTGX | Protagonist Therapeutics, Inc. | 9.39B | -0.58% | 529,502 | 281.99M |
| 120 | RGEN | Repligen Corporation | 9.31B | -2.06% | 1,077,460 | 785.10M |
| 121 | IONS | Ionis Pharmaceuticals, Inc. | 9.31B | -1.22% | 3,033,296 | 874.09M |
| 122 | PCVX | Vaxcyte, Inc. | 8.86B | -1.41% | 1,193,550 | - |
| 123 | QGEN | Qiagen N.V. | 8.79B | 0.28% | 1,097,249 | 2.10B |
| 124 | TXG | 10x Genomics, Inc. | 8.77B | 2.58% | 2,765,947 | 616.91M |
| 125 | IBRX | ImmunityBio, Inc. | 8.54B | -2.77% | 9,457,753 | 165.79M |
| 126 | BRKR | Bruker Corporation | 8.29B | -6.75% | 2,876,138 | 3.50B |
| 127 | IMVT | Immunovant, Inc. | 8.00B | -2.07% | 1,023,363 | - |
| 128 | TWST | Twist Bioscience Corporation | 7.87B | -1.98% | 1,832,872 | 431.80M |
| 129 | ATR | AptarGroup, Inc. | 7.76B | -1.79% | 380,676 | 3.93B |
| 130 | TGTX | TG Therapeutics, Inc. | 7.75B | -1.96% | 1,408,353 | 799.54M |
| 131 | SYRE | Spyre Therapeutics, Inc. | 7.66B | -4.25% | 1,003,729 | - |
| 132 | HQY | HealthEquity, Inc. | 7.66B | -0.75% | 693,354 | 1.36B |
| 133 | ALKS | Alkermes plc | 7.62B | -0.20% | 1,403,155 | 1.67B |
| 134 | BLTE | Belite Bio, Inc | 7.38B | -5.02% | 236,706 | - |
| 135 | HNGE | Hinge Health, Inc. | 7.37B | -1.49% | 1,490,728 | 720.06M |
| 136 | PACS | PACS Group, Inc. | 7.06B | 2.13% | 552,664 | 5.55B |
| 137 | RYTM | Rhythm Pharmaceuticals, Inc. | 6.96B | -0.73% | 481,146 | 239.92M |
| 138 | GRFS | Grifols, S.A. | 6.91B | 0.90% | 703,340 | 8.48B |
| 139 | CAI | Caris Life Sciences, Inc. | 6.79B | -3.18% | 3,111,757 | 989.61M |
| 140 | CHE | Chemed Corporation | 6.75B | -0.08% | 104,614 | 2.60B |
| 141 | SRRK | Scholar Rock Holding Corporation | 6.65B | -4.88% | 1,594,439 | - |
| 142 | LNTH | Lantheus Holdings, Inc. | 6.57B | 0.26% | 697,473 | 1.56B |
| 143 | HIMS | Hims & Hers Health, Inc. | 6.51B | -0.96% | 8,272,423 | 2.58B |
| 144 | MMED | MiniMed Group, Inc. | 6.40B | -2.40% | 1,586,221 | 3.22B |
| 145 | MIRM | Mirum Pharmaceuticals, Inc. | 6.38B | -1.24% | 500,994 | 618.07M |
| 146 | CGON | CG Oncology, Inc. | 6.38B | -1.96% | 685,303 | 6.23M |
| 147 | BLCO | Bausch + Lomb Corporation | 6.35B | 0.34% | 484,913 | 5.32B |
| 148 | TVTX | Travere Therapeutics, Inc. | 6.24B | 0.23% | 1,215,972 | 591.33M |
| 149 | LQDA | Liquidia Corporation | 6.19B | 2.13% | 996,832 | 450.91M |
| 150 | KNSA | Kiniksa Pharmaceuticals International, plc | 6.13B | 1.85% | 558,088 | 840.85M |
| 151 | ORKA | Oruka Therapeutics, Inc. | 6.06B | -2.98% | 511,143 | - |
| 152 | AMRX | Amneal Pharmaceuticals, Inc. | 6.01B | 1.17% | 1,471,826 | 3.12B |
| 153 | DNTH | Dianthus Therapeutics, Inc. | 5.99B | -1.92% | 1,033,749 | 1.90M |
| 154 | COGT | Cogent Biosciences, Inc. | 5.93B | -3.12% | 1,585,391 | - |
| 155 | TFX | Teleflex Incorporated | 5.75B | -0.93% | 484,158 | 2.25B |
| 156 | LGND | Ligand Pharmaceuticals Incorporated | 5.74B | -0.27% | 309,896 | 290.54M |
| 157 | XENE | Xenon Pharmaceuticals Inc. | 5.71B | -0.96% | 487,790 | 7.50M |
| 158 | PTCT | PTC Therapeutics, Inc. | 5.64B | -1.80% | 1,066,298 | 1.01B |
| 159 | RDNT | RadNet, Inc. | 5.58B | -1.53% | 574,473 | 2.27B |
| 160 | STVN | Stevanato Group S.p.A. | 5.53B | -0.39% | 221,237 | 1.40B |
| 161 | ERAS | Erasca, Inc. | 5.49B | -3.56% | 4,030,327 | - |
| 162 | SHC | Sotera Health Company | 5.23B | -1.40% | 1,977,704 | 1.22B |
| 163 | MMSI | Merit Medical Systems, Inc. | 5.21B | -0.22% | 474,366 | 1.58B |
| 164 | CRSP | CRISPR Therapeutics AG | 5.17B | -2.43% | 1,182,380 | 13.39M |
| 165 | DFTX | Definium Therapeutics, Inc. | 5.10B | -0.63% | 1,282,579 | - |
| 166 | LFST | LifeStance Health Group, Inc. | 4.82B | -1.41% | 12,459,507 | 1.58B |
| 167 | PBLS | Parabilis Medicines, Inc. | 4.79B | -2.54% | 499,399 | 148.00K |
| 168 | ACAD | ACADIA Pharmaceuticals Inc. | 4.77B | 0.36% | 1,244,571 | 1.14B |
| 169 | EWTX | Edgewise Therapeutics, Inc. | 4.71B | -0.98% | 692,518 | - |
| 170 | HAE | Haemonetics Corporation | 4.69B | 0.31% | 609,206 | 1.35B |
| 171 | BLLN | BillionToOne, Inc. | 4.68B | 0.10% | 545,374 | 397.41M |
| 172 | WAY | Waystar Holding Corp. | 4.58B | -1.57% | 1,295,470 | 1.21B |
| 173 | CELC | Celcuity Inc. | 4.41B | -3.16% | 703,664 | - |
| 174 | CON | Concentra Group Holdings Parent, Inc. | 4.36B | 0.89% | 647,951 | 2.29B |
| 175 | LIVN | LivaNova PLC | 4.35B | -2.19% | 671,006 | 1.47B |
| 176 | DOCS | Doximity, Inc. | 4.31B | -0.94% | 2,609,751 | 655.57M |
| 177 | ITGR | Integer Holdings Corporation | 4.28B | -0.27% | 1,130,852 | 1.84B |
| 178 | NVST | Envista Holdings Corporation | 4.24B | -1.45% | 1,881,862 | 2.86B |
| 179 | ELVN | Enliven Therapeutics, Inc. | 4.21B | -3.23% | 1,292,605 | - |
| 180 | MANE | Veradermics, Incorporated | 4.16B | -4.01% | 548,707 | - |
| 181 | INDV | Indivior Pharmaceuticals, Inc. | 4.10B | 1.31% | 1,341,452 | 1.33B |
| 182 | TLX | Telix Pharmaceuticals Limited | 4.09B | 3.01% | 544,517 | 890.79M |
| 183 | RLAY | Relay Therapeutics, Inc. | 4.09B | -2.35% | 6,373,951 | 10.35M |
| 184 | AMLX | Amylyx Pharmaceuticals, Inc. | 4.07B | -4.37% | 1,285,704 | -665.00K |
| 185 | HTFL | HeartFlow, Inc. | 4.06B | -2.26% | 1,407,846 | 212.07M |
| 186 | TNGX | Tango Therapeutics, Inc. | 4.05B | 5.73% | 4,663,877 | 53.81M |
| 187 | ICUI | ICU Medical, Inc. | 4.03B | 0.07% | 276,745 | 2.16B |
| 188 | IRTC | iRhythm Holdings, Inc. | 3.94B | -2.18% | 976,126 | 825.34M |
| 189 | ADPT | Adaptive Biotechnologies Corporation | 3.90B | 0.33% | 1,103,357 | 308.08M |
| 190 | LEGN | Legend Biotech Corporation | 3.86B | -2.83% | 1,362,980 | 1.27B |
| 191 | IOVA | Iovance Biotherapeutics, Inc. | 3.82B | -3.10% | 11,850,835 | 324.97M |
| 192 | VKTX | Viking Therapeutics, Inc. | 3.81B | -2.91% | 2,039,829 | - |
| 193 | PLSE | Pulse Biosciences, Inc. | 3.78B | 8.57% | 1,557,784 | 1.19M |
| 194 | IDYA | IDEAYA Biosciences, Inc. | 3.70B | -1.26% | 482,963 | 234.13M |
| 195 | TARS | Tarsus Pharmaceuticals, Inc. | 3.63B | -5.10% | 552,001 | 606.33M |
| 196 | RCUS | Arcus Biosciences, Inc. | 3.63B | -1.96% | 1,827,974 | 117.00M |
| 197 | OGN | Organon & Co. | 3.59B | -0.58% | 5,564,713 | 6.13B |
| 198 | DYN | Dyne Therapeutics, Inc. | 3.58B | -5.51% | 5,090,807 | - |
| 199 | ABCL | AbCellera Biologics Inc. | 3.58B | -3.41% | 2,396,045 | 66.17M |
| 200 | NHC | National HealthCare Corporation | 3.56B | 2.84% | 86,188 | 1.56B |
| 201 | OPCH | Option Care Health, Inc. | 3.54B | -0.42% | 1,394,598 | 5.69B |
| 202 | VCYT | Veracyte, Inc. | 3.53B | 3.32% | 1,446,070 | 561.90M |
| 203 | GRAL | GRAIL, Inc. | 3.46B | -2.05% | 589,676 | 165.26M |
| 204 | DNLI | Denali Therapeutics Inc. | 3.45B | -2.31% | 2,089,741 | 3.60M |
| 205 | QURE | uniQure N.V. | 3.19B | 0.70% | 1,304,013 | 18.67M |
| 206 | AVAH | Aveanna Healthcare Holdings Inc. | 3.06B | 2.64% | 3,136,667 | 2.60B |
| 207 | CLDX | Celldex Therapeutics, Inc. | 3.05B | -0.87% | 586,139 | 158.00K |
| 208 | WRBY | Warby Parker Inc. | 3.04B | -0.77% | 2,791,949 | 911.61M |
| 209 | MBX | MBX Biosciences, Inc. | 3.03B | -0.13% | 312,353 | - |
| 210 | ARQT | Arcutis Biotherapeutics, Inc. | 3.00B | -2.26% | 2,313,018 | 463.98M |
| 211 | TMDX | TransMedics Group, Inc. | 3.00B | -2.12% | 664,427 | 668.47M |
| 212 | IMNM | Immunome, Inc. | 2.97B | -2.57% | 782,293 | 4.02M |
| 213 | GPCR | Structure Therapeutics Inc. | 2.94B | 2.11% | 1,557,031 | - |
| 214 | IRON | Disc Medicine, Inc. | 2.94B | -0.43% | 714,651 | - |
| 215 | BKD | Brookdale Senior Living Inc. | 2.90B | 0.41% | 2,466,260 | 2.93B |
| 216 | RGC | Regencell Bioscience Holdings Limited | 2.90B | -14.22% | 291,351 | - |
| 217 | SLS | SELLAS Life Sciences Group, Inc. | 2.82B | -0.07% | 5,429,788 | - |
| 218 | ZLAB | Zai Lab Limited | 2.82B | -1.30% | 484,418 | 449.61M |
| 219 | GRDN | Guardian Pharmacy Services, Inc. | 2.75B | 2.21% | 518,562 | 1.46B |
| 220 | NRIX | Nurix Therapeutics, Inc. | 2.73B | 0.50% | 983,072 | 36.77M |
| 221 | NAMS | NewAmsterdam Pharma Company N.V. | 2.72B | -11.08% | 2,313,821 | 7.12M |
| 222 | ATAI | AtaiBeckley Inc. | 2.70B | 0.14% | 14,850,402 | 4.47M |
| 223 | ALHC | Alignment Healthcare, Inc. | 2.70B | -3.19% | 4,860,784 | 4.58B |
| 224 | ATRC | AtriCure, Inc. | 2.70B | -1.30% | 1,570,499 | 569.62M |
| 225 | MLYS | Mineralys Therapeutics, Inc. | 2.70B | -1.99% | 2,049,586 | - |
| 226 | PHVS | Pharvaris N.V. | 2.65B | -0.26% | 1,419,341 | - |
| 227 | ACHC | Acadia Healthcare Company, Inc. | 2.62B | 2.51% | 1,690,344 | 3.37B |
| 228 | PRVA | Privia Health Group, Inc. | 2.61B | -1.73% | 1,038,147 | 2.36B |
| 229 | NEOG | Neogen Corporation | 2.60B | 0.29% | 6,160,458 | 870.40M |
| 230 | CDNA | CareDx, Inc. | 2.59B | -0.56% | 1,213,956 | 458.09M |
| 231 | WGS | GeneDx Holdings Corp. | 2.58B | 0.71% | 492,556 | 454.43M |
| 232 | VRDN | Viridian Therapeutics, Inc. | 2.58B | -1.90% | 1,549,092 | 71.13M |
| 233 | AXGN | Axogen, Inc. | 2.54B | 1.24% | 630,144 | 251.17M |
| 234 | OCUL | Ocular Therapeutix, Inc. | 2.52B | 0.88% | 2,804,420 | 52.06M |
| 235 | BEAM | Beam Therapeutics Inc. | 2.52B | -6.17% | 2,827,436 | 156.04M |
| 236 | NKTR | Nektar Therapeutics | 2.50B | -2.81% | 929,631 | 54.59M |
| 237 | SUPN | Supernus Pharmaceuticals, Inc. | 2.45B | -0.85% | 579,607 | 830.44M |
| 238 | PGEN | Precigen, Inc. | 2.43B | -1.02% | 3,133,696 | 85.72M |
| 239 | VERA | Vera Therapeutics, Inc. | 2.43B | -4.25% | 938,783 | - |
| 240 | HRMY | Harmony Biosciences Holdings, Inc. | 2.42B | -1.07% | 1,132,872 | 959.90M |
| 241 | HCM | HUTCHMED (China) Limited | 2.38B | -2.23% | 94,719 | 549.12M |
| 242 | TRVI | Trevi Therapeutics, Inc. | 2.37B | -1.07% | 955,655 | - |
| 243 | SRPT | Sarepta Therapeutics, Inc. | 2.33B | 5.16% | 4,163,891 | 1.97B |
| 244 | PBH | Prestige Consumer Healthcare Inc. | 2.31B | -2.19% | 474,863 | 1.10B |
| 245 | CLOV | Clover Health Investments, Corp. | 2.31B | 1.17% | 4,390,734 | 2.48B |
| 246 | BHC | Bausch Health Companies Inc. | 2.30B | -4.20% | 1,424,304 | 10.85B |
| 247 | NUVB | Nuvation Bio Inc. | 2.29B | -1.36% | 2,561,962 | 169.90M |
| 248 | NEO | NeoGenomics, Inc. | 2.27B | 0.57% | 1,533,739 | 766.30M |
| 249 | TRLV | Trulieve Cannabis Corp. | 2.27B | -5.31% | 2,323,200 | 1.14B |
| 250 | BHVN | Biohaven Ltd. | 2.27B | 1.90% | 2,816,530 | - |
| 251 | BCRX | BioCryst Pharmaceuticals, Inc. | 2.25B | -2.87% | 5,147,896 | 940.61M |
| 252 | ESTA | Establishment Labs Holdings Inc. | 2.22B | -1.04% | 313,454 | 245.82M |
| 253 | URGN | UroGen Pharma Ltd. | 2.20B | 2.70% | 1,011,589 | 188.73M |
| 254 | ADUS | Addus HomeCare Corporation | 2.18B | -0.08% | 136,122 | 1.48B |
| 255 | PVLA | Palvella Therapeutics, Inc. | 2.18B | -0.62% | 148,250 | - |
| 256 | AUPH | Aurinia Pharmaceuticals Inc. | 2.16B | 1.12% | 722,868 | 311.51M |
| 257 | UFPT | UFP Technologies, Inc. | 2.16B | -0.93% | 130,814 | 631.64M |
| 258 | MD | Pediatrix Medical Group, Inc. | 2.15B | 0.56% | 712,909 | 1.95B |
| 259 | XRAY | DENTSPLY SIRONA Inc. | 2.14B | -2.46% | 3,218,085 | 3.64B |
| 260 | KOD | Kodiak Sciences Inc. | 2.12B | -3.68% | 642,195 | - |
| 261 | ADMA | ADMA Biologics, Inc. | 2.12B | -0.94% | 2,382,115 | 512.28M |
| 262 | RAPP | Rapport Therapeutics, Inc. | 2.11B | -4.78% | 436,799 | 20.00M |
| 263 | ZBIO | Zenas BioPharma, Inc. | 2.10B | -2.30% | 385,076 | 1.00M |
| 264 | CMPS | COMPASS Pathways plc | 2.10B | 8.05% | 7,688,658 | - |
| 265 | PGNY | Progyny, Inc. | 2.08B | -0.11% | 1,114,706 | 1.31B |
| 266 | MESO | Mesoblast Limited | 2.08B | -1.53% | 199,870 | 120.25M |
| 267 | COAG | Hemab Therapeutics Holdings, Inc. | 2.08B | -0.16% | 428,251 | - |
| 268 | AGIO | Agios Pharmaceuticals, Inc. | 2.07B | 3.22% | 1,023,877 | 98.34M |
| 269 | ALMR | Alamar Biosciences, Inc. | 2.01B | -3.31% | 185,818 | 100.42M |
| 270 | VCEL | Vericel Corporation | 2.00B | -0.23% | 366,511 | 306.30M |
| 271 | GENB | Generate Biomedicines, Inc. | 1.99B | -2.39% | 981,025 | 26.48M |
| 272 | PRGO | Perrigo Company plc | 1.99B | -1.65% | 2,701,963 | 4.14B |
| 273 | BFLY | Butterfly Network, Inc. | 1.99B | -0.80% | 4,120,785 | 112.14M |
| 274 | ASTH | Astrana Health, Inc. | 1.95B | -0.10% | 194,269 | 3.84B |
| 275 | STOK | Stoke Therapeutics, Inc. | 1.93B | -0.47% | 633,447 | 27.59M |
| 276 | ZYME | Zymeworks Inc. | 1.93B | -3.42% | 394,396 | 37.13M |
| 277 | KLRA | Kailera Therapeutics, Inc. | 1.92B | -9.68% | 743,293 | - |
| 278 | INSP | Inspire Medical Systems, Inc. | 1.92B | 6.98% | 1,183,295 | 898.74M |
| 279 | GHRS | GH Research PLC | 1.89B | -0.83% | 336,093 | - |
| 280 | SNDA | Sonida Senior Living, Inc. | 1.87B | 1.31% | 330,704 | 481.07M |
| 281 | ALVO | Alvotech | 1.86B | 0.39% | 570,679 | 494.61M |
| 282 | BRVE | Braveheart Bio, Inc. | 1.86B | -1.70% | 309,642 | - |
| 283 | XNCR | Xencor, Inc. | 1.85B | -1.54% | 1,142,089 | 104.97M |
| 284 | KARD | Kardigan, Inc. | 1.84B | -8.89% | 382,455 | - |
| 285 | NBTX | Nanobiotix S.A. | 1.84B | -4.06% | 105,450 | 38.27M |
| 286 | SGRY | Surgery Partners, Inc. | 1.83B | 1.15% | 1,679,962 | 3.37B |
| 287 | VIR | Vir Biotechnology, Inc. | 1.83B | -3.31% | 1,945,248 | 303.23M |
| 288 | NVCR | NovoCure Limited | 1.82B | -7.24% | 996,329 | 699.19M |
| 289 | LMAT | LeMaitre Vascular, Inc. | 1.82B | -0.15% | 309,068 | 262.43M |
| 290 | MRVI | Maravai LifeSciences Holdings, Inc. | 1.80B | -3.34% | 2,202,185 | 208.78M |
| 291 | LKFT | Lakefront Biotherapeutics NV | 1.80B | -0.72% | 130,029 | 1.13B |
| 292 | IMCR | Immunocore Holdings plc | 1.78B | -2.52% | 337,074 | 430.78M |
| 293 | SEPN | Septerna, Inc. | 1.77B | 1.61% | 475,114 | 98.88M |
| 294 | SNDX | Syndax Pharmaceuticals, Inc. | 1.77B | -0.50% | 1,237,075 | 252.25M |
| 295 | PSNL | Personalis, Inc. | 1.75B | -1.20% | 2,736,521 | 69.67M |
| 296 | TSHA | Taysha Gene Therapies, Inc. | 1.74B | -2.55% | 1,810,510 | 5.49M |
| 297 | RXRX | Recursion Pharmaceuticals, Inc. | 1.72B | -6.54% | 14,079,270 | 54.86M |
| 298 | NTLA | Intellia Therapeutics, Inc. | 1.71B | -4.16% | 4,885,019 | 59.51M |
| 299 | BLFS | BioLife Solutions, Inc. | 1.71B | -1.27% | 1,272,058 | 106.69M |
| 300 | FRNM | Freenome, Inc. | 1.69B | -1.50% | 400,941 | 35.41M |
| 301 | ETON | Eton Pharmaceuticals, Inc. | 1.68B | -0.87% | 367,524 | 105.60M |
| 302 | INBX | Inhibrx Biosciences, Inc. | 1.66B | -1.29% | 657,753 | 1.30M |
| 303 | ANAB | AnaptysBio, Inc. | 1.65B | -1.59% | 294,726 | 232.39M |
| 304 | NVAX | Novavax, Inc. | 1.62B | -3.34% | 4,436,700 | 413.80M |
| 305 | DMRA | Damora Therapeutics, Inc. | 1.62B | -9.94% | 499,956 | - |
| 306 | AAPG | Ascentage Pharma Group International | 1.60B | -0.75% | 1,639 | 94.61M |
| 307 | FTRE | Fortrea Holdings Inc. | 1.60B | -1.58% | 1,239,920 | 2.68B |
| 308 | AVLN | Avalyn Pharma Inc. | 1.59B | -4.63% | 168,566 | - |
| 309 | ARDT | Ardent Health, Inc. | 1.57B | 3.72% | 563,585 | 6.41B |
| 310 | AGL | agilon health, inc. | 1.57B | 2.43% | 147,832 | 5.92B |
| 311 | BCAX | Bicara Therapeutics Inc. | 1.56B | -0.30% | 550,065 | - |
| 312 | APMD | Apnimed, Inc. | 1.56B | -2.47% | 219,137 | 120.15M |
| 313 | LBRX | LB Pharmaceuticals Inc | 1.54B | -3.48% | 189,987 | - |
| 314 | OMCL | Omnicell, Inc. | 1.53B | -0.71% | 467,354 | 1.25B |
| 315 | INVA | Innoviva, Inc. | 1.53B | -0.98% | 847,152 | 440.00M |
| 316 | ANIP | ANI Pharmaceuticals, Inc. | 1.52B | 0.67% | 296,856 | 978.38M |
| 317 | HCSG | Healthcare Services Group, Inc. | 1.51B | 1.15% | 507,433 | 1.86B |
| 318 | LTGO | Latigo Biotherapeutics, Inc. | 1.51B | -3.92% | 190,365 | - |
| 319 | INNV | InnovAge Holding Corp. | 1.51B | 4.85% | 882,738 | 989.71M |
| 320 | PAHC | Phibro Animal Health Corporation | 1.49B | -1.37% | 176,607 | 1.52B |
| 321 | SLBT | SL Science Holding Limited | 1.49B | -0.38% | 52,167 | 3.27M |
| 322 | ABSI | Absci Corporation | 1.48B | -2.92% | 2,019,181 | 1.56M |
| 323 | AVBP | ArriVent BioPharma, Inc. | 1.47B | -1.62% | 279,889 | - |
| 324 | SDGR | Schrödinger, Inc. | 1.44B | -4.14% | 758,063 | 259.04M |
| 325 | TRAX | First Tracks Biotherapeutics, Inc. | 1.41B | -5.18% | 478,533 | - |
| 326 | KMTS | Kestra Medical Technologies, Ltd. | 1.41B | -6.10% | 303,107 | 95.13M |
| 327 | HROW | Harrow, Inc. | 1.41B | -0.79% | 354,480 | 275.59M |
| 328 | RARE | Ultragenyx Pharmaceutical Inc. | 1.41B | -3.83% | 4,562,731 | 717.00M |
| 329 | XERS | Xeris Biopharma Holdings, Inc. | 1.41B | -9.08% | 2,806,024 | 335.41M |
| 330 | CNMD | CONMED Corporation | 1.41B | 0.73% | 261,560 | 1.37B |
| 331 | OMER | Omeros Corporation | 1.40B | 1.41% | 1,529,461 | 38.42M |
| 332 | ATEC | Alphatec Holdings, Inc. | 1.39B | -2.23% | 3,053,105 | 815.05M |
| 333 | PNTG | The Pennant Group, Inc. | 1.38B | 0.74% | 254,991 | 1.10B |
| 334 | SVRA | Savara Inc. | 1.38B | -2.08% | 1,095,477 | - |
| 335 | VOR | Vor Biopharma Inc. | 1.37B | -7.43% | 824,750 | - |
| 336 | CGEM | Cullinan Therapeutics, Inc. | 1.37B | -1.75% | 1,277,651 | - |
| 337 | MAZE | Maze Therapeutics, Inc. | 1.37B | -6.79% | 397,272 | 20.00M |
| 338 | REPL | Replimune Group, Inc. | 1.36B | -2.17% | 1,073,766 | - |
| 339 | NUTX | Nutex Health Inc. | 1.35B | 3.68% | 184,153 | 846.72M |
| 340 | AKTS | Aktis Oncology, Inc. | 1.34B | -3.84% | 375,864 | 10.06M |
| 341 | ANRO | Alto Neuroscience, Inc. | 1.34B | -4.86% | 556,878 | - |
| 342 | AMN | AMN Healthcare Services, Inc. | 1.33B | 1.87% | 381,146 | 3.43B |
| 343 | TNDM | Tandem Diabetes Care, Inc. | 1.33B | -3.87% | 1,569,505 | 1.04B |
| 344 | AZTA | Azenta, Inc. | 1.32B | -2.17% | 837,348 | 613.81M |
| 345 | DRTS | Alpha Tau Medical Ltd. | 1.32B | -3.84% | 411,716 | - |
| 346 | OMDA | Omada Health, Inc. | 1.32B | -3.07% | 1,615,187 | 309.76M |
| 347 | TYRA | Tyra Biosciences, Inc. | 1.31B | -17.66% | 5,290,223 | - |
| 348 | ORIC | ORIC Pharmaceuticals, Inc. | 1.30B | -0.95% | 1,669,026 | - |
| 349 | MGTX | MeiraGTx Holdings plc | 1.27B | -2.00% | 533,600 | 397.50M |
| 350 | ALMS | Alumis Inc. | 1.27B | -7.37% | 3,872,319 | 7.40M |
| 351 | MNKD | MannKind Corporation | 1.27B | -5.29% | 4,917,490 | 393.63M |
| 352 | IART | Integra LifeSciences Holdings Corporation | 1.26B | -0.06% | 578,398 | 1.65B |
| 353 | IMTX | Immatics N.V. | 1.25B | -3.50% | 323,765 | 47.65M |
| 354 | AORT | Artivion, Inc. | 1.23B | 0.36% | 553,450 | 471.47M |
| 355 | GLUE | Monte Rosa Therapeutics, Inc. | 1.22B | -0.07% | 1,146,088 | 28.73M |
| 356 | JBIO | Jade Biosciences, Inc. | 1.21B | -2.01% | 1,502,156 | - |
| 357 | PRCT | PROCEPT BioRobotics Corporation | 1.19B | -2.86% | 1,069,565 | 337.34M |
| 358 | STAA | STAAR Surgical Company | 1.18B | -2.24% | 821,235 | 339.59M |
| 359 | JANX | Janux Therapeutics, Inc. | 1.18B | -3.54% | 575,981 | 24.00M |
| 360 | ODTX | Odyssey Therapeutics, Inc. | 1.17B | -9.12% | 217,271 | 99.00K |
| 361 | MLTX | MoonLake Immunotherapeutics | 1.17B | -8.17% | 1,690,059 | - |
| 362 | SPTX | Seaport Therapeutics, Inc. | 1.16B | -9.60% | 316,681 | - |
| 363 | CERT | Certara, Inc. | 1.16B | -1.42% | 1,462,304 | 421.75M |
| 364 | USPH | U.S. Physical Therapy, Inc. | 1.16B | -1.07% | 131,606 | 804.27M |
| 365 | CRON | Cronos Group Inc. | 1.16B | -0.94% | 603,630 | 179.09M |
| 366 | OBX | Obsidian Therapeutics, Inc. | 1.15B | -0.27% | 332,032 | - |
| 367 | OPK | OPKO Health, Inc. | 1.15B | -3.14% | 1,415,682 | 587.90M |
| 368 | BVS | Bioventus Inc. | 1.15B | -1.45% | 435,956 | 581.85M |
| 369 | GDRX | GoodRx Holdings, Inc. | 1.14B | -5.11% | 1,284,707 | 785.23M |
| 370 | CRVS | Corvus Pharmaceuticals, Inc. | 1.12B | -4.31% | 1,106,396 | - |
| 371 | TDOC | Teladoc Health, Inc. | 1.11B | -2.56% | 3,779,469 | 2.49B |
| 372 | ENOV | Enovis Corporation | 1.10B | -4.75% | 1,881,654 | 2.30B |
| 373 | LMRI | Lumexa Imaging Holdings, Inc. | 1.08B | -2.25% | 248,663 | 1.04B |
| 374 | KURA | Kura Oncology, Inc. | 1.08B | -3.43% | 2,211,448 | 77.23M |
| 375 | IRMD | IRADIMED CORPORATION | 1.07B | -1.00% | 74,262 | 86.34M |
| 376 | ATTO | Attovia Therapeutics, Inc. | 1.04B | -3.38% | 194,655 | 1.80M |
| 377 | IVA | Inventiva S.A. | 1.04B | -4.71% | 1,949,171 | 7.94M |
| 378 | PCRX | Pacira BioSciences, Inc. | 1.03B | 0.04% | 526,835 | 746.16M |
| 379 | SLDB | Solid Biosciences Inc. | 1.02B | -3.93% | 646,022 | - |
| 380 | ABUS | Arbutus Biopharma Corporation | 1.02B | -0.19% | 5,507,025 | 181.72M |
| 381 | GMRS | GMR Solutions Inc. | 1.02B | -5.22% | 522,438 | 5.88B |
| 382 | HELP | Cybin Inc. | 999.46M | 10.41% | 1,735,198 | - |
| 383 | CSTL | Castle Biosciences, Inc. | 987.05M | -1.37% | 194,237 | 357.28M |
| 384 | AMPH | Amphastar Pharmaceuticals, Inc. | 980.07M | 0.48% | 349,339 | 730.02M |
| 385 | AVTX | Avalo Therapeutics, Inc. | 976.60M | -7.61% | 725,496 | 59.00K |
| 386 | LXRX | Lexicon Pharmaceuticals, Inc. | 956.66M | -3.59% | 2,199,177 | 41.47M |
| 387 | SANA | Sana Biotechnology, Inc. | 948.97M | -8.12% | 8,637,746 | - |
| 388 | WVE | Wave Life Sciences, Inc. | 947.80M | -2.04% | 3,248,556 | 65.37M |
| 389 | ARDX | Ardelyx, Inc. | 946.91M | 0.80% | 4,472,716 | 450.89M |
| 390 | ANL | Adlai Nortye Group Ltd. | 946.33M | -5.25% | 161,793 | 18.06M |
| 391 | DSGN | Design Therapeutics, Inc. | 939.98M | -1.38% | 820,962 | - |
| 392 | CBLL | CeriBell, Inc. | 936.81M | 0.41% | 255,262 | 101.96M |
| 393 | FTH | Faeth Therapeutics, Inc. | 933.36M | -7.86% | 170,387 | - |
| 394 | CADL | Candel Therapeutics, Inc. | 931.23M | -3.41% | 660,661 | - |
| 395 | SGP | SpyGlass Pharma, Inc. | 919.82M | -4.79% | 78,433 | - |
| 396 | OLMA | Olema Pharmaceuticals, Inc. | 906.48M | -5.69% | 863,598 | - |
| 397 | GERN | Geron Corporation | 899.46M | -7.28% | 9,237,636 | 204.56M |
| 398 | TBPH | Theravance Biopharma, Inc. | 885.73M | - | 264,265 | 104.31M |
| 399 | RIGL | Rigel Pharmaceuticals, Inc. | 882.06M | -0.32% | 122,761 | 276.79M |
| 400 | IMMX | Immix Biopharma, Inc. | 880.65M | -7.09% | 1,286,110 | - |
| 401 | QDEL | QuidelOrtho Corporation | 866.79M | -5.53% | 866,348 | 2.67B |
| 402 | CLYM | Climb Bio, Inc. | 864.42M | -5.35% | 1,633,671 | - |
| 403 | CBIO | Crescent Biopharma, Inc. | 855.59M | -2.30% | 295,894 | 11.88M |
| 404 | INMD | InMode Ltd. | 850.14M | -0.14% | 621,116 | 374.63M |
| 405 | HSTM | HealthStream, Inc. | 838.31M | -0.17% | 221,980 | 321.12M |
| 406 | AVR | Anteris Technologies Global Corp. | 831.32M | -1.04% | 681,721 | 2.24M |
| 407 | ANNX | Annexon, Inc. | 828.46M | -6.42% | 5,527,362 | - |
| 408 | SIBN | SI-BONE, Inc. | 825.11M | -1.13% | 437,171 | 213.60M |
| 409 | ACRS | Aclaris Therapeutics, Inc. | 818.43M | -8.25% | 3,678,838 | 8.22M |
| 410 | SLN | Silence Therapeutics plc | 815.84M | -1.02% | 645,396 | 615.00K |
| 411 | DBVT | DBV Technologies S.A. | 810.89M | 1.28% | 89,617 | 5.04M |
| 412 | BBNX | Beta Bionics, Inc. | 783.72M | -9.93% | 848,721 | 119.01M |
| 413 | FDMT | 4D Molecular Therapeutics, Inc. | 783.36M | -3.08% | 493,073 | 92.01M |
| 414 | PHAR | Pharming Group N.V. | 782.22M | -4.61% | 12,118 | 366.48M |
| 415 | VREX | Varex Imaging Corporation | 779.74M | 0.05% | 1,439,353 | 865.00M |
| 416 | ACHV | Achieve Life Sciences, Inc. | 775.88M | -3.83% | 2,359,072 | - |
| 417 | CTMX | CytomX Therapeutics, Inc. | 771.36M | -3.01% | 2,052,491 | 18.30M |
| 418 | GLAS | Glass House Brands Inc. | 767.13M | -2.63% | 484,777 | 176.98M |
| 419 | MPLT | MapLight Therapeutics, Inc. | 761.94M | -1.72% | 500,625 | - |
| 420 | COLL | Collegium Pharmaceutical, Inc. | 760.50M | -0.04% | 1,077,066 | 808.21M |
| 421 | AHCO | AdaptHealth Corp. | 760.43M | -7.92% | 3,557,665 | 3.36B |
| 422 | NGNE | Neurogene Inc. | 758.03M | -0.66% | 193,102 | 925.00K |
| 423 | MNPR | Monopar Therapeutics Inc. | 754.31M | -1.75% | 91,660 | - |
| 424 | AURA | Aura Biosciences, Inc. | 746.67M | -2.17% | 465,860 | - |
| 425 | NVCT | Nuvectis Pharma, Inc. | 742.21M | -5.04% | 163,590 | - |
| 426 | GYRE | Gyre Therapeutics, Inc. | 736.93M | -3.07% | 104,699 | 109.82M |
| 427 | AGMB | AgomAb Therapeutics NV | 736.75M | 0.34% | 72,555 | - |
| 428 | VSTM | Verastem, Inc. | 719.07M | -1.73% | 2,399,675 | 87.53M |
| 429 | ZVRA | Zevra Therapeutics, Inc. | 714.98M | -5.01% | 922,861 | 136.07M |
| 430 | OCS | Oculis Holding AG | 708.07M | -5.67% | 164,355 | 1.45M |
| 431 | PHAT | Phathom Pharmaceuticals, Inc. | 688.66M | -8.06% | 1,109,240 | 239.66M |
| 432 | AHG | Akso Health Group | 685.45M | -2.04% | 952 | 13.83M |
| 433 | MDXG | MiMedx Group, Inc. | 682.16M | 0.21% | 1,048,736 | 355.17M |
| 434 | SGMT | Sagimet Biosciences Inc. | 675.04M | 1.40% | 1,225,278 | - |
| 435 | BLSM | BlossomHill Therapeutics, Inc. | 674.16M | -4.06% | 136,285 | - |
| 436 | IRWD | Ironwood Pharmaceuticals, Inc. | 672.53M | -2.40% | 1,473,875 | 389.32M |
| 437 | ASMB | Assembly Biosciences, Inc. | 669.25M | -6.83% | 724,307 | 74.85M |
| 438 | SOPH | SOPHiA GENETICS SA | 653.78M | -8.13% | 799,281 | 86.17M |
| 439 | ALT | Altimmune, Inc. | 651.63M | -0.30% | 3,052,371 | 31.00K |
| 440 | EVO | Evotec SE | 648.20M | -0.55% | 41,698 | 819.47M |
| 441 | AQST | Aquestive Therapeutics, Inc. | 646.38M | -1.15% | 1,882,288 | 54.09M |
| 442 | SSII | SS Innovations International, Inc. | 645.24M | -1.53% | 42,220 | 52.40M |
| 443 | DRUG | Bright Minds Biosciences Inc. | 642.77M | -2.76% | 43,196 | - |
| 444 | PHR | Phreesia, Inc. | 641.81M | 1.17% | 860,036 | 507.79M |
| 445 | STLN | Starling Oncology, Inc. | 641.05M | -0.47% | 845,988 | 587.24M |
| 446 | VALN | Valneva SE | 638.69M | -2.48% | 23,817 | 163.30M |
| 447 | STTK | Shattuck Labs, Inc. | 635.30M | -2.62% | 1,062,021 | 1.00M |
| 448 | CRMD | CorMedix Inc. | 633.69M | -0.61% | 924,351 | 462.25M |
| 449 | ANGO | AngioDynamics, Inc. | 633.21M | 0.66% | 328,754 | 320.17M |
| 450 | PRME | Prime Medicine, Inc. | 617.33M | -2.53% | 4,213,398 | 4.07M |
| 451 | CTEV | Claritev Corporation | 615.02M | -3.77% | 117,952 | 994.67M |
| 452 | CTKB | Cytek Biosciences, Inc. | 614.82M | 2.38% | 810,094 | 206.71M |
| 453 | ALLO | Allogene Therapeutics, Inc. | 597.70M | -6.99% | 7,271,280 | 4.64M |
| 454 | TECX | Tectonic Therapeutic, Inc. | 595.86M | 0.26% | 133,363 | - |
| 455 | WEAV | Weave Communications, Inc. | 583.99M | -0.14% | 1,777,856 | 257.79M |
| 456 | OABI | OmniAb, Inc. | 583.74M | -5.31% | 1,201,375 | 38.46M |
| 457 | EIKN | Eikon Therapeutics, Inc. | 581.19M | 0.19% | 751,173 | - |
| 458 | TLRY | Tilray Brands, Inc. | 576.74M | -2.09% | 4,632,831 | 915.45M |
| 459 | RGNX | REGENXBIO Inc. | 576.30M | -0.34% | 1,407,378 | 174.48M |
| 460 | ARVN | Arvinas, Inc. | 572.78M | -3.52% | 738,186 | 316.70M |
| 461 | BWAY | BrainsWay Ltd. | 570.74M | 1.77% | 128,955 | 60.70M |
| 462 | CTNM | Contineum Therapeutics, Inc. | 569.58M | -5.02% | 388,824 | - |
| 463 | KIDS | OrthoPediatrics Corp. | 566.06M | -2.43% | 97,192 | 252.72M |
| 464 | EOLS | Evolus, Inc. | 566.05M | -3.49% | 996,465 | 316.49M |
| 465 | PROK | ProKidney Corp. | 559.30M | -7.04% | 1,408,389 | 818.00K |
| 466 | SCTX | Scribe Therapeutics Inc. | 556.78M | -6.16% | 153,060 | 33.30M |
| 467 | DCTH | Delcath Systems, Inc. | 554.49M | -0.62% | 384,631 | 95.42M |
| 468 | ZURA | Zura Bio Limited | 547.18M | -6.85% | 1,728,882 | - |
| 469 | FLGT | Fulgent Genetics, Inc. | 546.18M | -1.73% | 369,930 | 323.93M |
| 470 | BBOT | BridgeBio Oncology Therapeutics, Inc. | 541.58M | -23.76% | 1,499,467 | - |
| 471 | AUTL | Autolus Therapeutics plc | 540.31M | -3.79% | 1,709,712 | 117.39M |
| 472 | EPRX | Eupraxia Pharmaceuticals Inc. | 529.14M | -2.06% | 186,532 | - |
| 473 | ARTV | Artiva Biotherapeutics, Inc. | 527.52M | -0.83% | 325,051 | 251.00K |
| 474 | OVID | Ovid Therapeutics Inc. | 527.30M | -1.82% | 1,261,775 | 1.58M |
| 475 | PRLD | Prelude Therapeutics Incorporated | 524.24M | -3.96% | 311,515 | 22.42M |
| 476 | SPRY | ARS Pharmaceuticals, Inc. | 520.11M | -2.97% | 871,250 | 116.93M |
| 477 | CERS | Cerus Corporation | 505.83M | -1.18% | 874,060 | 221.55M |
| 478 | MCTA | Charming Medical Limited | 504.26M | -0.85% | - | 4.81M |
| 479 | CAPR | Capricor Therapeutics, Inc. | 502.32M | -4.64% | 2,730,030 | 11.13M |
| 480 | TCMD | Tactile Systems Technology, Inc. | 498.80M | 1.33% | 317,741 | 350.31M |
| 481 | NPCE | NeuroPace, Inc. | 497.70M | -1.76% | 78,578 | 106.99M |
| 482 | CABA | Cabaletta Bio, Inc. | 493.38M | -11.01% | 6,466,886 | - |
| 483 | ENTX | Entera Bio Ltd. | 491.72M | -5.65% | 621,287 | 42.00K |
| 484 | PRTA | Prothena Corporation plc | 477.43M | -2.52% | 294,145 | 54.53M |
| 485 | IRD | Opus Genetics, Inc. | 476.71M | 32.03% | 52,207,153 | 9.86M |
| 486 | KMDA | Kamada Ltd. | 474.38M | -0.97% | 106,882 | 191.85M |
| 487 | KYTX | Kyverna Therapeutics, Inc. | 472.48M | -5.33% | 918,015 | - |
| 488 | EVH | Evolent Health, Inc. | 469.20M | -1.66% | 1,864,251 | 2.10B |
| 489 | PBYI | Puma Biotechnology, Inc. | 467.16M | -3.62% | 452,825 | 231.24M |
| 490 | NRC | NRC Health | 462.96M | -1.23% | 129,628 | 140.00M |
| 491 | SRTA | Strata Critical Medical, Inc. | 461.80M | -1.69% | 768,645 | 255.98M |
| 492 | SENS | Senseonics Holdings, Inc. | 461.06M | -6.54% | 767,950 | 48.55M |
| 493 | DNA | Ginkgo Bioworks Holdings, Inc. | 457.24M | -2.16% | 889,025 | 132.42M |
| 494 | SGHT | Sight Sciences, Inc. | 443.46M | -0.62% | 167,159 | 83.38M |
| 495 | IKT | Inhibikase Therapeutics, Inc. | 438.80M | -0.82% | 323,416 | 1.00 |
| 496 | RLMD | Relmada Therapeutics, Inc. | 436.28M | -3.76% | 1,589,322 | - |
| 497 | BNTC | Benitec Biopharma Inc. | 427.71M | -2.16% | 69,992 | - |
| 498 | EDIT | Editas Medicine, Inc. | 425.42M | -8.58% | 2,958,144 | 47.01M |
| 499 | RZLT | Rezolute, Inc. | 424.14M | -7.73% | 2,054,983 | - |
| 500 | CLPT | ClearPoint Neuro, Inc. | 423.40M | -1.21% | 449,711 | 42.28M |